Chair Radiology and Interventional Oncology at RGCIRC.

Home / Posts Tagged "Chair Radiology and Interventional Oncology at RGCIRC."

Krsnaa Diagnostics delivers strong performance with revenues of Rs. 241 Cr, EBITDA* of Rs. 74 Cr with margins of 30.9% in H1 FY22 Revenue up by 19%, EBITDA* up by 76% and PAT without CCPS is up by 167% y-o-y

October 12, 2021

5:36 am

Krsnaa Diagnostics Ltd. (BSE: 543328 | NSE: KRSNAA) is one of India’s fastest growing diagnostic service providers, both in radiology and pathology. The Company today announced the results for first six months ending 30th September 2021, following its listing on the stock exchanges on 16th

POST TAGS:

Chair Radiology and Interventional Oncology at RGCIRC.employees Executive Director healthcare diagnostic Himachal Pradesh Karnataka Krsnaa Diagnostics Maharashtra Mr. Yash Mutha Punjab

Rajiv Gandhi Cancer Institute and Research Centre strengthens its imaging capability with ‘MAGNETOM Vida’, the first MRI with BioMatrix Technology in Delhi and NCR region

July 14, 2021

10:33 am

News Update

admin

Rajiv Gandhi Cancer Institute and Research Centre is one of the premier cancer centers in Asia founded in the year 1996. The institute offers cutting-edge technology and renowned specialists for patients from India and neighboring countries. It specializes in tertiary care services in Medical, Surgical

POST TAGS:

Chair Radiology and Interventional Oncology at RGCIRC.Dr. Arvind K Chaturvedi Head of MRI business at Siemens Healthineers India Rajiv Gandhi Cancer Institute and Research Centre Subodh Divgi

Krsnaa Diagnostics delivers strong performance with revenues of Rs. 241 Cr, EBITDA* of Rs. 74 Cr with margins of 30.9% in H1 FY22 Revenue up by 19%, EBITDA* up by 76% and PAT without CCPS is up by 167% y-o-y

POST TAGS:

Rajiv Gandhi Cancer Institute and Research Centre strengthens its imaging capability with ‘MAGNETOM Vida’, the first MRI with BioMatrix Technology in Delhi and NCR region

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA